Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%
- Check20 days agoChange DetectedPage update: version bumped to v3.1.0 and a specific resource topic (Head and neck squamous cell carcinoma) removed.SummaryDifference0.5%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The Back to Top element was removed as a minor UI change.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has added a facility name and location, along with specific resources related to head and neck squamous cell carcinoma and pembrolizumab, while removing various location-related terms and several related topics.SummaryDifference4%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.